PTGDS and asthma: As corticosteroids inhibit and downregulate the expression of cyclooxygenase (COX)2 and subsequent PGD2 production20–22, we hypothesized that the continuation of standard-of-care corticosteroid treatment, as occurred in the majority of trials, may have decreased the effectiveness of DP2 antagonism in the treatment of asthma.